ERCP术后早期并发症及防治的研究进展
The Risk Factors and Prevention for the ERCP Early Postoperative Complications Research Progress
DOI: 10.12677/ACM.2017.73031, PDF, HTML, XML, 下载: 1,570  浏览: 18,701 
作者: 刘 娱, 张永洁：延安大学医学院，陕西 延安；宗 伟, 朱云清：陕西省人民医院消化内科，陕西 西安
关键词: ERCP；术后早期并发症；危险因素；防治措施；ERCP； the Early Postoperative Complications Risk Factors； Preventive Measures
摘要: 经内镜逆行性胰胆管造影术(ERCP)现已成为消化内科一项重要的诊疗手段，目前主要应用于梗阻性黄疸、胆道疾患(如结石、肿瘤、胆管炎)、胰腺疾病(如胰腺炎、胰腺肿瘤、胰腺囊肿)等相关疾病的诊治，而其术后相关的早期并发症也受到越来越多人的关注，其中包括胰腺炎、消化道出血、胆管炎、穿孔、心肺并发症等，一旦未得到及时有效的处理，则易导致死亡。本文通过对目前ERCP术后早期并发症相关危险因素及防治措施的研究进展进行综述，以期提高临床医师对这些并发症的正确认识以及指导临床医师积极有效防治并发症的发生。
Abstract: Endoscopic Retrograde Cholangiopancreatography (ERCP) has became an important means of di-agnosis and treatment in the department of gastroenterology, mainly used in obstructive jaundice, biliary diseases (such as choledocholithiasis, tumor cholangitis), pancreatic diseases (such as pancreatitis, pancreatic cancer, pancreatic cyst) and its early postoperative complications also have gotten more and more people's attention, including acute pancreatitis, bleeding, cholangitis, perforation, cardiopulmonary complications. Once not timely and effective treatment, it is easy to lead to death. This paper is going to review the risk factors and prevention for the ERCP early postoperative complications research progress, in order to improve the clinical physicians for the correct understanding of these complications and to guide the clinician positive and effective prevention and treatment of complications.
文章引用：刘娱, 宗伟, 张永洁, 朱云清. ERCP术后早期并发症及防治的研究进展 [J]. 临床医学进展, 2017, 7(3): 190-197. https://doi.org/10.12677/ACM.2017.73031

参考文献

[1] 中华医学会消化内镜分会ERCP学组, 胡冰, 麻树人, 李兆申. 内镜下逆行胆胰管造影术(ERCP)诊治指南(2010版) [J]. 中国继续医学教育, 2010, 2(6): 1-20.
[2] 郭学刚, 吴开春. 内镜逆行胰胆管造影[M]. 北京: 人民军医出版社, 2015.
[3] 黄书明, 陈圣开. ERCP术后并发急性胰腺炎的高危因素分析和预防[J]. 贵州医药, 2016(7): 738-739.
[4] 刘国栋, 罗东, 肖瑶. 内镜逆行性胰胆管造影术后并发症分析: 附461例报告[J]. 中国普通外科杂志, 2015(9): 1275-1280.
[5] Ding, X., Zhang, F. and Wang Y. (2015) Risk Factors for Post-ERCP Pancreatitis: A Systematic Review and Meta-Analysis. Surgeon, 13, 218-229.
https://doi.org/10.1016/j.surge.2014.11.005
[6] Freeman, M.L., DiSario, J.A., Nelson, D.B., et al. (2001) Risk Factors for Post-ERCP Pancreatitis: A Prospective, Multicenter Study. Gastrointestinal Endoscopy, 54, 425-434.
https://doi.org/10.1067/mge.2001.117550
[7] TestoIIi, P.A. (2002) Why the Incidence of Post-ERCP Pancreatitis Varies Considerably? Factors Affecting the Diagnosis and the Incidence of this Complication. Journal of the Pancreas, 3, 195-201.
[8] Von Seth, E., Arnelo, U., Enochsson, L., et al. (2015) Primary Sclerosing Cholangitis Increases the Risk for Pancreatitis after Endoscopic Retrograde Cholangiopancreatography. Liver International, 35, 254-262.
https://doi.org/10.1111/liv.12640
[9] 徐秀云. ERCP术后胰腺炎及高淀粉酶血症的危险因素分析[D]: [硕士学位论文]. 安徽: 皖南医学院, 2015.
[10] Li, N., Tieng, A. and Novak, S. (2010) Effects of Medications on Post-Endoscopic Retrograde Cholangiopancreatography pancreatits. Pancreatology, 10, 238-242.
https://doi.org/10.1159/000279306
[11] 常圆, 杨甜, 关景明. ERCP术后胰腺炎预防的研究进展[J]. 胃肠病学和肝病学杂志, 2013, 22(4): 302-306.
[12] 刘雪莲, 杨见权, 潘昭杰. 直肠使用吲哚美辛预防内镜逆行胰胆管造影取石术后胰腺炎的Meta分析[J]. 中国新药与临床杂志, 2017(4): 238-244.
[13] Luo, H., Zhao, L., et al. (2016) Routine Pre-Procedural Rectal Indometacin versus Selective Post-Procedural Rectal Indometacin to Prevent Pancreatitis in Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Multicentre, Single-Blinded, Randomised Controlled Trial. The Lancet, 387, 2293-2301.
[14] 蔡永国, 白笠, 董堃博. 生长抑素联合埃索美拉唑对胆管结石ERCP术后胰腺炎及高胰淀粉酶血症的预防效果[J]. 齐齐哈尔医学院学报, 2017(6): 672-673.
[15] 刘蓉安, 王一平, 吴娅秋. 头孢他啶对预防内镜逆行胰胆管造影术后发生胰腺炎的疗效研究[J]. 现代生物医学进展, 2017(8): 1498-1501.
[16] 王翀. 大黄预防ERCP术后胰腺炎的疗效观察[C]//中国中西医结合学会消化系统疾病专业委员会. 第二十五届全国中西医结合消化系统疾病学术会议论文集. 2013: 1.
[17] 卢静, 王春晖, 钟显飞. 经内镜逆行胰胆管造影术后胰腺炎预防进展[J]. 华西医学, 2017(2): 262-266.
[18] Choudhary, A., Bechtold, M.L., Arif, M., et al. (2011) Pancreatic Stents for Prophylaxis against Post-ERCP Pancreatitis: A Meta-Analysis and Systematic Review. Gastrointestinal Endoscopy, 73, 275-282.
[19] 郭学刚. 不容忽视的ERCP围手术期全程管理[J]. 天津医药, 2016(5): 513-517.
[20] 徐洪根, 马进. 治疗性ERCP术后十二指肠乳头出血与原发疾病的关系[J]. 世界华人消化杂志, 2017(8): 755-759.
[21] Baek, Y.H., Kim, H.J., Park, J.H., et al. (2009) Risk Factors for Recurrent Bile Duct Stones after Endoscopic Clearance of Common Bile Duct Stones. The Korean Journal of Gastroenterology, 54, 36-41.
https://doi.org/10.4166/kjg.2009.54.1.36
[22] 汪润芝. 经内镜乳头括约肌切开胆总管取石术并发出血的危险因素及治疗分析[D]: [博士学位论文]. 武汉: 武汉大学, 2015.
[23] 张宏昭. ERCP术后早期并发症的影响因素分析[D]: [硕士学位论文]. 西宁: 青海大学, 2016.
[24] Boustiere, C., Veitch, A., Vanbiervliet, G., et al. (2011) En-doscopy and Antiplatelet Agents. European Society of Gastrointestinal Endoscopy (ESGE) Guidelines. Endoscopy, 43, 445-461.
https://doi.org/10.1055/s-0030-1256317
[25] Katsinelos, P., Lazaraki, G., Chatzimavroudis, G., et al. (2014) Risk Factors for Therapeutic ERCP-Related Complications: An Analysis of 2715 Cases Performed by a Single Endoscoplist. Annals of Gastroenterology, 27, 65-72.
[26] 周春霞. EST术后迟发性乳头切口出血危险因素分析及防治措施[D]: [硕士学位论文]. 南昌: 南昌大学, 2016.
[27] Freeman, M.L. (1997) Complications of Endoscopic Biliary Sphincterotomy. Endoscopy, 29, 288-297.
https://doi.org/10.1055/s-2007-1004193
[28] 杨建峰, 张啸. 内镜下十二指肠乳头括约肌切开并发出血的原因、处理及预防[J]. 中华消化内镜杂志, 2008, 25(7): 38-39.
[29] Fujimoto, K., Fujishiro, M., Kato, M., et al. (2014) Guidelines for Gastroenterological Endoscopy in Patients Undergoing Abtithrombotic Treatment. Digestive Endoscopy, 26, J-14.
[30] 张燕霞, 黄茜, 马久红. 急诊内镜下治疗内镜下逆行胰胆管造影术后十二指肠乳头出血27例临床分析[J]. 中国内镜杂志, 2016, 2: 83-86.
[31] 陈敏, 魏威, 姚玉玲. ERCP术后胆管炎相关危险因素分析[J]. 胃肠病学, 2016(7): 419-423.
[32] 徐平平. ERCP术后并发症的危险因素研究及ERCP术后预防性使用抗生素的价值探讨[D]: [硕士学位论文]. 南昌: 南昌大学, 2015.
[33] 张雨雨, 刘坤. ERCP术后胆管炎的相关因素分析[J]. 中国医疗器械信息, 2016(7): 14-16 + 61.
[34] Kostrzewska, M., Baniukiewicz, A., Wroblewski, E., et al. (2011) Com-plications of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Their Risk Factors. Advances in Medical Sciences, 56, 6-12.
https://doi.org/10.2478/v10039-011-0012-4
[35] Cotton, P.B., et al. (2008) Infection after ERCP, and Antibiotic Prophylaxis: A Sequential Quality-Improvement Approach over 11 Years. Gastrointestinal Endoscopy, 67, 471-475.
[36] Brand, M., et al. (2010) Antibiotic Prophylaxis for Patients Undergoing Elective Endoscopic Retrograde Cholangiopancreatography. The Cochrane Database of Systematic Reviews, CD007345.
[37] ASGE Standards of Practice Committee, Anderson, M.A., Fisher, L., Jain, R., et al. (2012) Complications of ERCP. Gastrointestinal Endoscopy, 75, 467-473.
[38] Tapfer, M., Selby, R.R., Stain, S.C., et al. (2000) Management of Duodenal Perforation after Endoscopic Retrograde Cholangiopancreatography and Sphincterotomy. Annals of Surgery, 232, 191-198.
[39] Loperfido, S., Angelini, G., Benedetti, G., et al. (1998) Maj or Early Complications from Diagnostic and Therapeutic ERCP: Aprospective Multicenter Study. Gastrointestinal Endoscopy, 48, 1-10.
[40] 李兆申, 许国铭. 诊断性与治疗性 ERCP早期并发症与处理[J]. 中华消化内镜杂志, 2002, 19(2): 77-80.
[41] 余璐, 邓涛, 占义军, 等. ENBD预防胆总管结石ERCP术后急性胰腺炎及高淀粉酶血症的临床价值[J]. 胃肠病学和肝病学杂志, 2012, 21(4): 316-318.
[42] 依尔潘•艾山, 高峰. 经内镜逆行胰胆管造影术后高淀粉酶血症的危险因素分析[J]. 临床肝胆病杂志, 2016(1): 119-122.
[43] Chen, J.J., Wang, X.M., Liu, X.Q., et al. (2014) Risk Factors for Post-ERCP Pan-creatitis: A Systematic Review of Clinical Trials with a Large Sample Size in the Past 10 Years. European Journal of Medical Research, 19, 1-7.

为你推荐